DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bleomycin (Bleomycin) - Pulmonary Toxicity - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pulmonary Toxicity (5)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Bleomycin where reactions include pulmonary toxicity. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Bleomycin side effects in male

Reported by a physician from Greece on 2012-08-09

Patient: male

Reactions: Pulmonary Toxicity, Dyspnoea, Haemoptysis, Haemorrhage, Pancytopenia, Pyrexia, Bone Marrow Toxicity

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bleomycin
    Dosage: 30 mg, for 3 days
    Indication: Testis Cancer

Cisplatin
    Dosage: 50 mg/m2, days 1 and 2
    Indication: Testis Cancer

Etoposide
    Dosage: 165 mg/m2, days 1-3
    Indication: Testis Cancer



Possible Bleomycin side effects in 30 year old male

Reported by a physician from Israel on 2012-05-29

Patient: 30 year old male

Reactions: Pulmonary Toxicity, Respiratory Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Etoposide
    Dosage: 300 mg/m2,for 6 cycles
    Indication: Hodgkin's Disease

Prednisone TAB
    Dosage: 280 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 700 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Bleomycin
    Dosage: 10 mg/m2,for 6 cycles
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22

Patient:

Reactions: Pulmonary Toxicity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10u/m2 - cycle 3

Dacarbazine
    Dosage: cycle 2

Dacarbazine
    Dosage: cycle 6

Interferon Alfa
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Dosage: cycle 1

Dacarbazine
    Dosage: cycle 3

Interferon Alfa
    Dosage: given day 1-4

Bleomycin
    Dosage: 10u/m2 - cycle 1

Vinblastine Sulfate
    Dosage: cycle 6
    Indication: Hodgkin's Disease

Dacarbazine
    Dosage: cycle 5
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: 1 cycle
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: cycle 5

Bleomycin
    Dosage: 10u/m2 - cycle 5

Dacarbazine
    Dosage: cycle 1

Doxorubicin Hydrochloride
    Dosage: cycle 2

Interferon Alfa

Vinblastine Sulfate
    Dosage: cycle 3

Dacarbazine
    Dosage: cycle 4

Doxorubicin Hydrochloride
    Dosage: cycle 4

Interferon Alfa

Interferon Alfa

Vinblastine Sulfate
    Dosage: cycle 5

Vinblastine Sulfate
    Dosage: cycle 2

Doxorubicin Hydrochloride
    Dosage: cycle 3

Doxorubicin Hydrochloride
    Dosage: cycle 6

Bleomycin
    Dosage: 10u/m2 - cycle 2
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Dosage: cycle 4

Interferon Alfa

Bleomycin
    Dosage: 10u/m2 - cycle 6

Bleomycin
    Dosage: 10u/m2 - cycle 4



Possible Bleomycin side effects in 52 year old male

Reported by a physician from Israel on 2012-05-21

Patient: 52 year old male

Reactions: Pulmonary Toxicity, Respiratory Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Dacarbazine
    Dosage: 375 mg/m2
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Dosage: 6 g/m2
    Indication: Hodgkin's Disease

Dexamethasone
    Dosage: 20mg
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2
    Indication: Hodgkin's Disease

Bleomycin
    Dosage: 10 mg/m2
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in 30 year old male

Reported by a physician from Israel on 2012-05-21

Patient: 30 year old male

Reactions: Pulmonary Toxicity, Respiratory Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Prednisone
    Dosage: 280 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Bleomycin
    Dosage: 10 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Cytoxan
    Dosage: 650 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 300 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 700 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014